ATP1B1 and neoplasm: As ccRCC progresses, increased methylation of the promoter of ATPase Na/K transporting subunit beta 1 (ATP1B1) decreases its expression in cancer, thereby inhibiting tumor progression and acting as a cancer suppressor (29, 30).